About Janssen Labs
Accelerating Discovery to Treatment
Janssen Labs is a life science innovation center created by Janssen Research & Development, LLC (JRD) at its La Jolla-based West Coast Research Center. By providing emerging healthcare companies with many big company advantages, Janssen Labs offers a capital efficient way for companies to discover and develop solutions to the healthcare challenges we face today. This model is intended to give companies the opportunity to invest their capital in research instead of infrastructure and to focus resources on progressing science instead of day-to-day operations.
Companies at Janssen Labs occupy modular and scalable lab units, designed to grow with the companies, while access to core research facilities with specialized equipment and administrative areas make it easier to do business. Janssen Labs' daily operations are supported Prescience International, an external, award-winning team specialized in the creation and management of innovation centers. Through this “no strings attached” model, JRD does not take an equity stake in the companies occupying Janssen Labs and the companies are free to develop products - either on their own, or by initiating a separate external partnership with JRD or any other company.
“A thriving biotech ecosystem is crucial for the success of the pharmaceutical industry as a whole,” - Diego Miralles, M.D., site head for Janssen Research & Development LLC’s West Coast Research Center. “Recent challenges in the economic environment have made it difficult for many emerging biotech companies. We believe that supporting and nurturing these companies will be good for the entire industry.”
Janssen Labs is part of Janssen Research & Development, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Paul Janssen was a world renowned Belgian physician and scientist. With 50,000 francs (less than US $2,000) from his father, Dr. Janssen founded a research laboratory and then went on to found Janssen Pharmaceutica, a company that discovered 80 new medicines. Paul Janssen’s story embodies much of what we hope to achieve with Janssen Labs. In that same entrepreneurial spirit, Janssen Labs is the home for high-potential companies looking to transform healthcare with novel discoveries and limited upfront investment.
“Across sectors, stages and geographies, entrepreneurs and start-up companies are interested in this ‘no-strings-attached’ capital-efficient model to progress their scientific work. Our goal with Janssen Labs is to give novel technologies a greater opportunity to reach the patient by reducing some of the hurdles of early stage discovery,” continued Dr. Miralles.
About Janssen Research & Development
Janssen Research & Development, LLC, is united and energized by one mission – to discover and develop innovative medicines that ease patients' suffering.
As one of the Janssen Pharmaceutical Companies, Janssen R&D’s strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. Janssen R&D leverages world-class discovery and development expertise and operational excellence, to bring innovative, effective treatments in five therapeutic areas:
- cardiovascular and metabolism,
- immunology,
- infectious diseases and vaccines,
- neuroscience, and
- oncology
About Janssen R&D’s Strategic Partnerships
Janssen R&D’s strategy is to harness the best science in the world, whether from its own laboratories, or through strategic relationships and collaborations with academia, biotech and other pharmaceutical companies.
Janssen R&D currently has more than 100 ongoing collaborations and alliances globally. These strategic relationships take many forms, but the goal is always the same: to advance scientific research to deliver innovative, differentiated solutions that provide value to patients, physicians and health care systems.
